Neurothera Labs Inc. (NTLX.V)
TSXV · CAD · Healthcare · Drug Manufacturers - General
CA$1.62 (+0.62%) as of
Key statistics
- Market cap
- 137.54M
- EPS (TTM)
- -1.1900
- Dividend yield
- 0.00%
- 52-week range
- 1.6100 – 5.3200
- Beta
- -0.02
- Revenue (TTM)
- 680k
- Profit margin
- 0.00%
- Volume
- 714.00
About Neurothera Labs Inc.
Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware. Neurothera Labs Inc. is a subsidiary of SciSparc Ltd.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Newark, DE, United States
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.